- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 12:06 | Xenon Pharmaceuticals Inc.: Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) | 96 | X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo (p=0.000000000006)X-TOLE2... ► Artikel lesen | ||
| 12:06 | Rapport Therapeutics, Inc.: Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China | 99 | Partnership leverages Tenacia's expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights... ► Artikel lesen | ||
| 12:06 | NovaBridge Biosciences: NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study | 176 | VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 inhibitorTopline Phase 2a data show VIS-101 provides rapid, robust and durable treatment... ► Artikel lesen | ||
| 12:06 | Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer | 57 | Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time Tolerability... ► Artikel lesen | ||
| 12:06 | Nasdaq, Inc.: Nasdaq to launch equity token design, putting issuers at the center of tokenization | 75 | Nasdaq to support the tokenization of equities in a manner that preserves issuer control, existing regulatory frameworks, and the underlying rights associated with company shares Nasdaq's equity... ► Artikel lesen | ||
| 12:06 | Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | 79 | Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved:... ► Artikel lesen | ||
| 12:06 | Nobel Resources Corp.: Nobel Identifies New Mineralized Porphyry Copper System, Cuprita Project, Chile | 176 | TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- Nobel Resources Corp. (TSX - V: NBLC) (the "Company" or "Nobel") is pleased to announce that it has identified a new mineralized, copper porphyry system... ► Artikel lesen | ||
| 12:06 | 3D Systems Reports Fourth Quarter and Full Year 2025 Financial Results | 198 | ROCK HILL, S.C., March 09, 2026 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2025. Fourth quarter... ► Artikel lesen | ||
| 12:06 | Applied Optoelectronics, Inc.: AOI Receives First Volume Order of 1.6T Data Center Transceivers from Major Hyperscale Customer | 549 | SUGAR LAND, Texas, March 09, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics Inc. (NASDAQ: AAOI), a leading provider of advanced optical and HFC networking products that power AI, today announced... ► Artikel lesen | ||
| 12:06 | PyroGenesis Inc.: PyroGenesis Announces $1 Million Non-Brokered Private Placement | 47 | MONTREAL, March 09, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. ("PyroGenesis" of "the Company") (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation... ► Artikel lesen | ||
| 12:06 | Castle Biosciences, Inc.: DecisionDx-Melanoma's i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk | 35 | Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous Melanoma Guidelines recommend avoiding a sentinel lymph node (SLN) biopsy... ► Artikel lesen | ||
| 12:06 | Editas Medicine, Inc.: Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates | 95 | Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 Preparing to initiate Company's first-in-human clinical... ► Artikel lesen | ||
| 12:06 | Boundless Bio, Inc.: Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights | 181 | KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1... ► Artikel lesen | ||
| 12:00 | GRK Infra Oyj: GRK selected to carry out improvements on Main Road 4 in Estonia, contract value approximately EUR 38 million | 237 | 9.3.2026 13:00:01 EET | GRK Infra Oyj |
Investor News
GRK Infra Plc Investor News 9 March 2026 at 1.00 p.m. EET
GRK will... ► Artikel lesen | ||
| 11:36 | NOVA MINERALS LIMITED: Nova Announces Further High-Grade Gold Discovered at RPM | 77 | Anchorage Alaska, March 09, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Limited ("Nova" or the "Company") (NASDAQ: NVA) (ASX: NVA) (FRA: QM3)) is pleased to announce assay results from its 2025 surface... ► Artikel lesen | ||
| 11:36 | G Mining Ventures Corp.: G Mining Ventures Receives Notice of Exercise of Top-up Right from La Mancha | 95 | BROSSARD, Quebec, March 09, 2026 (GLOBE NEWSWIRE) -- G Mining Ventures Corp. ("GMIN" or the "Corporation") (TSX:GMIN, OTCQX:GMINF) announces that the Corporation's largest shareholder, La Mancha S.a.r.L.... ► Artikel lesen | ||
| 11:34 | Renk Group AG: Anja Mänz-Siebje, Acquisition | 331 | Renk Group AG: Anja Mänz-Siebje, Acquisition
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them... ► Artikel lesen | ||
| 11:18 | TRX Gold Corporation: TRX Gold Reports 2026 Annual Meeting Voting Results | 61 | TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the "Company" or "TRX Gold") is pleased to announce the voting results from its Annual General and... ► Artikel lesen | ||
| 11:10 | Quest Software Inc.: Quest Software Survey Finds That Over 75 Percent of Global Organizations Are Not Testing Identity Disaster Recovery Frequently Enough | 239 | Survey of 650 global IT and security leaders reveals that fewer than one-quarter of companies test disaster recovery every six months, and 24 percent never test their plans at allAUSTIN, Texas, March... ► Artikel lesen | ||
| 11:10 | Sant Joan de Déu Hospital Ward upgrades energy technology with Schneider Electric KNX Solutions, cutting energy costs by 40% | 249 | Maternity ward achieved electricity savings of 35% during the day and 50% during the night compared to conventional climate controls with SpaceLogic KNX.SpaceLogic KNX automation solution both increased... ► Artikel lesen | ||
| 11:06 | ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy (epinephrine nasal spray) Commercialization | 498 | neffy delivers $72.2 million of U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million... ► Artikel lesen | ||
| 11:00 | Woodward, Inc.: Woodward Announces Agreement to Acquire Valve Research & Manufacturing | 231 | ~Acquisition Will Complement Woodward's Aerospace Controls Portfolio~ FORT COLLINS, Colo., March 09, 2026 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ: WWD) today announced it has entered into an agreement... ► Artikel lesen | ||
| 10:54 | HyOrc Corporation: Energy Sovereignty: Localized Methanol Production Emerges as Strategic Alternative to Volatile Oil Routes | 146 | NEW YORK and PORTO, Portugal, March 09, 2026 (GLOBE NEWSWIRE) -- Global shipping's dependence on fuel moving through narrow maritime chokepoints such as the Strait of Hormuz is drawing renewed attention... ► Artikel lesen | ||
| 10:36 | HUTCHMED (China) Limited: HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK in China | 174 | HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:HCM; HKEX:13) today announces an update regarding... ► Artikel lesen | ||
| 10:35 | H. Lundbeck A/S: Lundbeck announces last patient randomized ahead-of-schedule in Phase 3 MASCOT trial | 81 | MASCOT is a first-of-its-kind, Phase 3 trial supporting the development of amlenetug, an investigational therapy for people living with multiple system atrophy (MSA), a rare and fatal neurodegenerative... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.